Interwell Health Appoints New Chief Medical Officer to Lead Value-Based Kidney Care Strategy

Interwell Health has shared an update. The company has appointed Carney Taylor, MD, MBA, an experienced nephrologist and leader in value-based kidney care, as its new chief medical officer. In this role, Dr. Taylor will oversee clinical strategy, physician engagement, and quality initiatives. Interwell Health also announced the retirement of its outgoing CMO, Dr. George Hart, acknowledging his role in shaping the company’s mission and growth.

For investors, the CMO transition highlights Interwell Health’s continued focus on value-based kidney care and clinical quality, which are central to its business model and partnerships with payers and providers. Strong clinical leadership can support the company’s ability to improve patient outcomes, manage costs in chronic kidney disease populations, and potentially strengthen its competitive position in the kidney care management and population health market. If Dr. Taylor’s strategy enhances physician alignment and measurable quality performance, it could improve the company’s attractiveness to risk-bearing entities and support long-term revenue growth and contract retention, though the financial impact will depend on execution and the broader reimbursement environment for value-based care.